会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • N-ACETYL-L-CYSTEINE FOR THE TREATMENT OF ENDOMETRIOSIS
    • 用于治疗子宫内膜异位症的N-乙酰-L- CYSTEINE
    • US20120238627A1
    • 2012-09-20
    • US13428984
    • 2012-03-23
    • Tiziana ParasassiMaria Grazia Porpora
    • Tiziana ParasassiMaria Grazia Porpora
    • A61K31/195A61P25/00A61P15/00C07C321/14
    • A61K31/198
    • The invention relates to a new prescription of NAC in the treatment of endometriosis and of indications associated with endometriosis, in a human or mammalian animal patient. In addition an effective dose regimen of NAC in the treatment of endometriosis is proposed. In one embodiment of the present invention the prescribed treatment regimen may be used e.g. in order to control the frequency and the intensity of pain symptoms (dysmenorrhea, dyspareunia and acyclic chronic pelvic pain), to reduce the size of endometriotic lesions eventually up to their disappearance, to reduce recurrences after surgery and/or to improve fertility. Side effects of this treatment are virtually absent and, in particular, this treatment does not hinder pregnancy.
    • 本发明涉及NAC在人或哺乳动物患者中治疗子宫内膜异位症和与子宫内膜异位症有关的适应症的新处方。 另外提出了NAC治疗子宫内膜异位症的有效剂量方案。 在本发明的一个实施方案中,可以使用规定的治疗方案。 为了控制疼痛症状的频率和强度(痛经,性交痛和非循环性慢性盆腔疼痛),最终减少子宫内膜异位病变的大小消失,减少手术后复发和/或改善生育能力。 这种治疗的副作用几乎不存在,特别是这种治疗不妨碍怀孕。
    • 10. 发明授权
    • N-acetyl-L-cysteine for the treatment of endometriosis
    • N-乙酰-L-半胱氨酸用于治疗子宫内膜异位症
    • US08637573B2
    • 2014-01-28
    • US13428984
    • 2012-03-23
    • Tiziana ParasassiMaria Grazia Porpora
    • Tiziana ParasassiMaria Grazia Porpora
    • A61K31/195C07C321/00
    • A61K31/198
    • The invention relates to a new prescription of NAC in the treatment of endometriosis and of indications associated with endometriosis, in a human or mammalian animal patient. In addition an effective dose regimen of NAC in the treatment of endometriosis is proposed. In one embodiment of the present invention the prescribed treatment regimen may be used e.g. in order to control the frequency and the intensity of pain symptoms (dysmenorrhea, dyspareunia and acyclic chronic pelvic pain), to reduce the size of endometriotic lesions eventually up to their disappearance, to reduce recurrences after surgery and/or to improve fertility. Side effects of this treatment are virtually absent and, in particular, this treatment does not hinder pregnancy.
    • 本发明涉及NAC在人或哺乳动物患者中治疗子宫内膜异位症和与子宫内膜异位症有关的适应症的新处方。 另外提出了NAC治疗子宫内膜异位症的有效剂量方案。 在本发明的一个实施方案中,可以使用规定的治疗方案。 为了控制疼痛症状的频率和强度(痛经,性交痛和非循环性慢性盆腔疼痛),最终减少子宫内膜异位病变的大小消失,减少手术后复发和/或改善生育能力。 这种治疗的副作用几乎不存在,特别是这种治疗不妨碍怀孕。